GlassScriptPhysician profile
Aye Aung Lwin
NPI 1750737136
$5,651.14
in general payments reported to CMS, 2019-2025
29 companies · $1,939 in 2025
The $1,939 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $75.66 · 2021: $65.00 · 2022: $635 · 2023: $461 · 2024: $2,475 · 2025: $1,939.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,570 · Consulting Fee: $1,000 · Travel and Lodging: $202 · Education: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,570.43 |
| Consulting Fee | $1,000.00 |
| Travel and Lodging | $202.39 |
| Education | $102.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,919.85 | 2020-2025 | Rezum Generator, Moses 550 Dfl, Moses |
| Medtronic, INC. | $679.93 | 2022-2025 | Altaviva, Interstim |
| Sumitomo Pharma America, INC. | $371.57 | 2024-2025 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $209.15 | 2021-2025 | |
| Urogen Pharma, INC. | $187.95 | 2023-2025 | Jelmyto |
| Pfizer INC. | $177.32 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $131.22 | 2024 | Lynparza |
| Procept Biorobotics Corporation | $121.13 | 2022 | |
| Coloplast Corp | $104.67 | 2021-2025 | Speedicath |
| Tolmar, INC. | $84.18 | 2023 | |
| Sun Pharmaceutical Industries INC. | $76.61 | 2022-2024 | Yonsa |
| Progenics Pharmaceuticals, INC. | $68.51 | 2023-2024 | Pylarify |
| 180 Medical, INC. | $64.10 | 2021-2025 | Gentlecath Glide |
| Abbvie INC. | $47.02 | 2021-2025 | |
| Axonics, INC. | $43.82 | 2022-2023 | Axonics, Bulkamid |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $40.47 | 2023-2025 | Erleada |
| Astellas Pharma US INC | $38.05 | 2022-2023 | Xtandi |
| Verity Pharmaceuticals INC. | $33.32 | 2023 | Trelstar |
| Intuitive Surgical, INC. | $32.48 | 2024 | |
| Ferring Pharmaceuticals INC. | $31.53 | 2024-2025 | Adstiladrin |
| Novartis Pharmaceuticals Corporation | $30.58 | 2024 | |
| Laborie Medical Technologies Corp. | $26.99 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Merck Sharp & Dohme LLC | $22.19 | 2023 | Lynparza, Welireg, Keytruda |
| Angiodynamics, INC. | $21.65 | 2024 | Nanoknife |
| Tolmar Pharmaceuticals, INC. | $20.31 | 2022 | |
| Myriad Genetic Laboratories, INC. | $19.13 | 2024 | Prolaris |
| Teleflex LLC | $17.02 | 2022 | |
| Cook Medical LLC | $15.34 | 2025 | Cook |
| Smith+Nephew, INC. | $15.05 | 2023 | Stravix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aye Lwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.